They found that delphinidin sensitized prostate cancer cells to TRAIL-induced apoptosis by activating DR5 and caspase-mediated cleavage of histonedeacetylase 3 (HDAC3). This evidence concerns the gene TNFRSF10B and Familial prostate cancer.